MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.ejphar.2023.175612

Медицинская библиотека · European journal of pharmacology · 2023

The molecular mechanisms of apoptosis accompanied with the epigenetic regulation of the NY-ESO-1 antigen in non-small lung cancer cells treated with decitabine (5-aza-CdR).

Inchakalody Varghese P, Hydrose Shereena P, Krishnankutty Roopesh, Merhi Maysaloun, Therachiyil Lubna, Sasidharan Nair Varun, Elashi Asma A, Khan Abdul Q, Taleb Sara, Raza Afsheen, Yoosuf Zeenath Safira K M, Fernandes Queenie, Al-Zaidan Lobna, Mestiri Sarra, Taib Nassiba, Bedhiafi Takwa, Moustafa Dina, Assami Laila, Maalej Karama Makni, Elkord Eyad, Uddin Shahab, Al Homsi Ussama, Dermime Said

СтатьяПеревод пока не подготовлен

Аннотация

Dysregulated epigenetic modifications are common in lung cancer but have been reversed using demethylating agent like 5-Aza-CdR. 5-Aza-CdR induces/upregulates the NY-ESO-1 antigen in lung cancer. Therefore, we investigated the molecular mechanisms accompanied with the epigenetic regulation of NY-ESO-1 in 5-Aza-CdR-treated NCI-H1975 cell line. We showed significant induction of the NY-ESO-1 protein (**p < 0.0097) using Cellular ELISA. Bisulfite-sequencing demonstrated 45.6% demethylation efficiency at the NY-ESO-1 gene promoter region and RT-qPCR analysis confirmed the significant induction of NY-ESO-1 at mRNA level (128-fold increase, *p < 0.050). We then investigated the mechanism by which 5-Aza-CdR inhibits cell proliferation in the NCI-H1975 cell line. Upregulation of the death receptors TRAIL (2.04-fold *p < 0.011) and FAS (2.1-fold *p < 0.011) indicate activation of the extrinsic apoptotic pathway. The upregulation of Voltage-dependent anion-selective channel protein 1 (1.9-fold), Major vault protein (1.8-fold), Bax (1.16-fold), and Cytochrome C (1.39-fold) indicate the activation of the intrinsic pathway. We also observed the differential expression of protein Complement C3 (3.3-fold), Destrin (-5.1-fold), Vimentin (-1.7-fold), Peroxiredoxin 4 (-1.6-fold), Fascin (-1.8-fold), Heme oxygenase-2 (-0.67-fold**p < 0.0055), Hsp27 (-0.57-fold**p < 0.004), and Hsp70 (-0.39-fold **p < 0.001), indicating reduced cell growth, cell migration, and metastasis. The upregulation of 40S ribosomal protein S9 (3-fold), 40S ribosomal protein S15 (4.2-fold), 40S ribosomal protein S18 (2.5-fold), and 60S ribosomal protein L22 (4.4-fold) implied the induction of translation machinery. These results reiterate the decisive role of 5-Aza-CdR in lung cancer treatment since it induces the epigenetic regulation of NY-ESO-1 antigen, inhibits cell proliferation, increases apoptosis, and decreases invasiveness.

Для цитирования: Inchakalody Varghese P, Hydrose Shereena P, Krishnankutty Roopesh, Merhi Maysaloun, Therachiyil Lubna, Sasidharan Nair Varun, Elashi Asma A, Khan Abdul Q, Taleb Sara, Raza Afsheen, Yoosuf Zeenath Safira K M, Fernandes Queenie, Al-Zaidan Lobna, Mestiri Sarra, Taib Nassiba, Bedhiafi Takwa, Moustafa Dina, Assami Laila, Maalej Karama Makni, Elkord Eyad, Uddin Shahab, Al Homsi Ussama, Dermime Said. The molecular mechanisms of apoptosis accompanied with the epigenetic regulation of the NY-ESO-1 antigen in non-small lung cancer cells treated with decitabine (5-aza-CdR).. European journal of pharmacology. 2023. DOI: 10.1016/j.ejphar.2023.175612.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.